Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Administration of the Passiflora Extract for Benzodiazepine Withdrawal in Institutionalized Older Adults: Clinical Trial Phase III

NCT03780595 is registered in ClinicalTrials.gov with Nutricion Medica S.L. as lead sponsor.

NCT NCT03780595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03780595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Administration of the Passiflora Extract for Benzodiazepine Withdrawal in Institutionalized Older Adults: Clinical Trial Phase III
Lead sponsor
Nutricion Medica S.L.
Phase
Phase 4
Overall status
Unknown status
Start date
September 27, 2018
Completion date
December 31, 2019
Enrollment
108 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

benzodiazepine withdrawal (disorder)